Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 537 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 03/01/20
End: 03/01/22
Due: 03/01/23
Phase: N/A
Priority: Normal
Start: 02/28/13
End: 11/30/14
Due: 11/30/15
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 01/31/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/15
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 03/31/12
Due: 03/31/13
Phase: N/A
Priority: Normal
Start: 08/01/16
End: 07/24/17
Due: 07/24/18
Phase: N/A
Priority: Normal
Start: 05/01/17
End: 05/01/19
Due: 05/01/20
Phase: N/A
Priority: Normal
Start: 11/08/17
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 05/31/09
End: 05/31/10
Due: 05/31/11
Phase: N/A
Priority: Normal
Start: 11/30/04
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 05/11/22
End: 10/31/24
Due: 10/31/25
Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor
Phase: N/A
Priority: Normal
Start: 01/31/19
End: 06/30/21
Due: 06/30/22
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 01/31/11
Due: 01/31/12
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 07/31/08
End: 08/31/10
Due: 08/31/11
Phase: N/A
Priority: Normal
Start: 12/31/11
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 11/23/19
End: 12/23/21
Due: 12/23/22
Phase: N/A
Priority: Normal
Start: 07/31/07
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 02/28/17
End: 07/23/17
Due: 07/23/18
Phase: N/A
Priority: Normal
Start: 08/20/23
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 02/17/20
End: 03/01/21
Due: 03/01/22
Phase: N/A
Priority: Normal
Start: 12/31/09
End: -
Due: -